LFLais Almeida Figueiredo

Lais Almeida Figueiredo

*This is an algorithmically generated author record based on publicly available information.

Lais Almeida Figueiredo has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Metabolic brain changes in post-acute COVID-19: systematic review and meta-analysis of [18F]-FDG-PET findings

    by Izabella Fernanda Bastos Siqueira, Lais Almeida Figueiredo, Camila Emanuele Moreira Fernandes, Leandro Pinheiro Cintra, Glauber Fernandes de Oliveira, Maria Angélica Rios, Ricardo Maciel, Rodrigo Ferretjans, Nathalia Sernizon Guimarães, Luiz Alexandre Viana Magno

    Individuals with long COVID exhibit neurological and psychiatric symptoms that often persist well beyond the initial SARS-CoV-2 infection. Studies using [18F]-FDG positron emission tomography (FDG-PET) have revealed diverse abnormalities in brain glucose metabolism during the post-acute phase of COVID-19. We conducted a systematic review and meta-analysis to assess the spatial distribution and heterogeneity of brain metabolic changes in patients in the post-acute phase of COVID-19 relative to controls. We searched the MEDLINE, EMBASE, and CENTRAL databases in June 2025 for studies reporting FDG-PET data in patients with post-acute COVID-19 who have persistent neurological symptoms. Of the 14 eligible studies (584 scans), 13 reported glucose hypometabolism across frontoparietal regions, with the frontal cortex being the most consistently affected. This finding was confirmed by meta-analysis, which revealed a large and significant effect in the frontal cortex (Hedges’ g = 1.34; 95% CI: 0.79–1.88; p < 0.001), despite high heterogeneity (I2 = 93.6%). The systematic review indicates that brain metabolism generally improves over time, with widely varying recovery timelines, and consistently correlates hypometabolism with neurological symptom burden. These findings underscore the clinical relevance of frontoparietal hypometabolism in post-acute COVID-19 and its association with neurocognitive deficits, highlighting the need for longitudinal, quantitative PET studies to elucidate temporal dynamics and inform therapeutic development.


  • Open Access

    Interações medicamentosas em prescrições de pacientes com controle inadequado da anticoagulação por dois ambulatórios especializados

    by Gabrielle de Matos Maranha, Lais Almeida Figueiredo, Julia Satler Gonçalves Silva, Camila Emanuele Moreira Fernandes, Caryne Margotto Bertollo, Josiane Moreira da Costa, Maria Auxiliadora Parreiras Martins

    Objective: to identify medication prescriptions for elderly patients undergoing anticoagulant treatment and potential interactions with warfarin. Methodology: Descriptive study, with patients with atrial fibrillation, over 18 years of age, treated at the anticoagulation outpatient clinics of two hospitals in Belo Horizonte, between June and December 2018, using warfarin for at least six months. Patients at these outpatient clinics were approached to identify medication prescriptions made by primary care doctors. The variables were analyzed: medications used and potential drug interactions with warfarin, observing the frequencies through the database created in an Excel spreadsheet. Results: at Hospital 1, 127 patients were evaluated, with a median age of 66 years, the majority of whom were men (50.4%). The most commonly used medications were: simvastatin (21.3%), spironolactone (14.6%) and omeprazole (11.9%). Of the total number of patients, 106 use medications that can interact with warfarin. At Hospital 2, 105 patients were evaluated, with a median age of 65 years, the majority of whom were women (67.6%). The most prescribed medications were: simvastatin (19.6%), omeprazole (15.8%) and acetylsalicylic acid (14.2%). At this institution, 99 patients used medications that could interact with warfarin. Conclusion: there is a high frequency of prescription of medications that interact with warfarin in the populations studied, reinforcing the need for therapeutic monitoring. Objetivo: identificar prescripciones de medicamentos para pacientes ancianos en tratamiento anticoagulante y posibles interacciones con warfarina. Metodología: Estudio descriptivo, con pacientes con fibrilación auricular, mayores de 18 años, atendidos en ambulatorios de anticoagulación de dos hospitales de Belo Horizonte, entre junio y diciembre de 2018, utilizando warfarina durante al menos seis meses. Se contactó a los pacientes de estas clínicas ambulatorias para identificar las prescripciones de medicamentos realizadas por los médicos de atención primaria. Se analizaron las variables: medicamentos utilizados y posibles interacciones farmacológicas con warfarina, observándose las frecuencias a través de la base de datos creada en una hoja de cálculo Excel. Resultados: en el Hospital 1 fueron evaluados 127 pacientes, con una mediana de edad de 66 años, la mayoría hombres (50,4%). Los medicamentos más utilizados fueron: simvastatina (21,3%), espironolactona (14,6%) y omeprazol (11,9%). Del total de pacientes, 106 utilizan medicamentos que pueden interactuar con la warfarina. En el Hospital 2 se evaluaron 105 pacientes, con una mediana de edad de 65 años, la mayoría mujeres (67,6%). Los medicamentos más prescritos fueron: simvastatina (19,6%), omeprazol (15,8%) y ácido acetilsalicílico (14,2%). En esta institución, 99 pacientes utilizaron medicamentos que podrían interactuar con la warfarina. Conclusión: existe una alta frecuencia de prescripción de medicamentos que interactúan con la warfarina en las poblaciones estudiadas, lo que refuerza la necesidad de seguimiento terapéutico. Objetivo: identificar prescrições medicamentosas de pacientes idosos em tratamento anticoagulante e potencial de interações com a varfarina. Metodologia: Estudo descritivo, com portadores de fibrilação atrial, maiores de 18 anos, atendidos nos ambulatórios de anticoagulação de dois hospitais de Belo Horizonte, entre junho e dezembro de 2018, em uso de varfarina por no mínimo seis meses. Os pacientes desses ambulatórios foram abordados para identificação de prescrição de medicamentos realizada por médicos da atenção primária. Analisou-se as variáveis: medicamentos utilizados e interações medicamentosas potenciais com a varfarina, observando-se as frequências através do banco de dados criado em planilha de Excel. Resultados: no Hospital 1, avaliaram-se 127 pacientes, com idade mediana de 66 anos, sendo majoritariamente homens (50,4%). Os medicamentos mais utilizados foram: sinvastatina (21,3%), espironolactona (14,6%) e omeprazol (11,9%). Do total de pacientes, 106 utilizam medicamentos que podem interagir com a varfarina. No Hospital 2, avaliaram-se 105 pacientes, com idade mediana de 65 anos, sendo majoritariamente mulheres (67,6%). Os medicamentos mais prescritos foram: sinvastatina (19,6%), omeprazol (15,8%) e ácido acetilsalicílico (14,2%). Nessa instituição, 99 pacientes utilizaram medicamentos que podem interagir com a varfarina. Conclusão: há uma alta frequência de prescrição de medicamentos que interagem com a varfarina nas populações estudadas, reforçando a necessidade de monitoramento terapêutico.